Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
211 participants
INTERVENTIONAL
1996-09-30
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Outcomes After Medical and Surgical Treatment of Gastroesophageal Reflux Disease
NCT00260572
Observational Study (This Means That no Drug is Tested) in Patients Suffering of Gastroesophageal Reflux Disease.
NCT01601379
Analysis of GERD Symptoms Using Gastroesophageal Reflux Impact Score Questionnaire for Quality of Life
NCT01536080
Correlates of GERD Symptom Severity
NCT03020550
Assessment of GERD Knowledge Level Among Patients With it in Korea
NCT02049723
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
HEALTH_SERVICES_RESEARCH
SINGLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
A
Patient education
An educational program: Three lessons spaced over 2 weeks.
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Patient education
An educational program: Three lessons spaced over 2 weeks.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* needing relief at least 5 days/ week when symptoms were at their worst
* disease history at least 3 months
* ability to give informed consent
Exclusion Criteria
* continuous need of proton pump inhibitors or NSAIDs
* wish for surgical treatment
* earlier surgical treatment in the GI-tract
* pregnancy
* alcohol or drug abuse
20 Years
75 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Norwegian Foundation for Health and Rehabilitation
OTHER
Norwegian University of Science and Technology
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Norwegian University of Science and Technology
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Jorgen A Urnes, MD
Role: PRINCIPAL_INVESTIGATOR
Norwegian University of Science and Technology
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Norwegian University of Science and Technology, Med. fac.
Trondheim, , Norway
Countries
Review the countries where the study has at least one active or historical site.
References
Explore related publications, articles, or registry entries linked to this study.
Urnes J, Farup PG, Lydersen S, Petersen H. Patient education in gastro-oesophageal reflux disease: a randomized controlled trial. Eur J Gastroenterol Hepatol. 2007 Dec;19(12):1104-10. doi: 10.1097/MEG.0b013e3282f163dc.
Urnes J, Petersen H, Farup PG. Disease knowledge after an educational program in patients with GERD--a randomized controlled trial. BMC Health Serv Res. 2008 Nov 13;8:236. doi: 10.1186/1472-6963-8-236.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
SLKNR 96/00515
Identifier Type: -
Identifier Source: secondary_id
Sak 33-96 (REK)
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.